Volume Management of the Critically Ill Patient Receiving RRT with Data from the Crit-Line Monitor

At the end of this presentation, you will have a better understanding of the goals and key factors associated with volume management of the critically ill patient undergoing renal replacement therapy.  We will review treatments options available in the acute setting where Crit-Line can be utilized. And you will understand the data provided by the Crit-Line and its role in the acute setting.  

All webinars are eligible for continuing education (CE) credits. Registration is required to receive CE credits. Please click the Register button above (if applicable, this button only appears for an upcoming course) to create an account (if necessary), and register for this session. Following the webinar, you will receive an email with a post-webinar CE survey. The survey must be completed in order to get a CE credit certificate. Fresenius Medical Care North America Renal is approved by the California Board of Registered Nursing (Provider # CEP 7570) to provide continuing education credits. Eligible participant(s) can receive credit; however, it is their responsibility to check with their licensing board to determine if they accept continuing education contact hours from the California Board of Registered Nursing.

If you would like to attend the webinar, but do not need CE credits, you do not need to pre-register. When it is time for the webinar, a general link can be accessed by clicking the down arrow (˅) next to the Register button above. This window will expand and the general link will appear under the presenter name. Copy and paste this link into your website browser to attend. 

Use: Crit-Line Technology is designed to non-invasively measure hematocrit, oxygen saturation and percent change in blood volume. The technology employs a sensor clip which emits multiple wavelengths of light to trans-illuminate the blood in the  Crit-Line blood chamber. The differences in light absorption between blood constituents allow for the identification and measurement of the hematocrit. The measurement of hematocrit, percent change in blood  volume and oxygen saturation in real-time during hemodialysis is intended  to provide a more effective treatment for both the dialysis patient and the  clinician. Based on the data that the monitor provides, the clinician/nurse, under physician direction, can intervene (i.e., by increasing or decreasing the rate at which fluid is removed from the blood) to remove the maximum amount  of fluid from the dialysis patient without the patient experiencing the common complications of dialysis which include nausea, cramping and vomiting. The technology is available as a stand-alone device (Crit-Line IV Monitor) or as an optional module on the 2008T hemodialysis machine series (CLiC™ device).

Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices.  For a complete description of hazards, contraindications, side effects, and  precautions, see full package labeling at fmcna.com.

© 2022 Fresenius Medical Care. All Rights Re­served. Fresenius Medical Care, the triangle logo, 2008T BlueStar, Crit-Line, and CLiC are trademarks of Fresenius Medical Care Hold­igs, Inc. or its affiliated companies. All other trademarks are the property of their respective owners.